Maximum quantity allowed is 999
请选择数量
CAS RN: 155148-31-5 | 產品號碼: P2620
AMD-3100 Octahydrochloride
×
![]()
×
纯度/分析方法: >98.0%(HPLC)
別名
- Plerixafor Octahydrochloride
- JM-3100
- SID-791
- 1,4-Bis[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]benzene Octahydrochloride
- 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane Octahydrochloride
文件：
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | P2620 |
| 純度/分析方法 | >98.0%(HPLC) |
| 分子式 / 分子量 | C__2__8H__5__4N__8·8HCl = 794.46 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Frozen (-20°C) |
| 應避免的情況 | Heat Sensitive |
| 包裝和容器 | 100MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 155148-31-5 |
| Reaxys-RN | 8182245 |
| PubChem Substance ID | 468592637 |
| MDL編號 | MFCD04974488 |
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Precipitation Titration) | min. 95.0 % |
| NMR | confirm to structure |
性質
| 熔點 | 245 °C |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| 防範說明 | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
相關法規
| RTECS # | XA5255300 |
運輸資料
| HS編碼* | 2933.99-000 |
Application
AMD-3100 Octahydrochloride: A CXC Chemokine Receptor Type 4 (CXCR4) Antagonist
AMD-3100 octahydrochloride (plerixafor octahydrochloride) is an antagonist of CXC chemokine receptor type 4 (CXCR4), which is a chemokine receptor expressed on immune cells and cancer cells. CXCR4 antagonists, including AMD-3100, were initially developed for the treatment of HIV-1 (AIDS), where CXCR4 functions as a co-receptor for virus entry into T cells.1) Subsequently, CXCR4 antagonists were noticed to induce leukocytosis, and are currently used for mobilization of hematopoietic stem cells.2,3) Recently, it has been reported that CXCR4 induces migration of cancer cells and is important for processes such as metastasis.3,4) Therefore, CXCR4 antagonists are expected to regulate these tumor metastatic processes. (The product is for research purpose only.)
References
- 1) AMD3100, a small molecule inhibitor of HIV-1 entry via the CXC4 co-receptor
- 2) Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
- 3) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers (a review)
- 4) CXCR4 in breast cancer: oncogenic role and therapeutic targeting
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。